C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/83 (2006.01) A61K 31/70 (2006.01) A61K 35/30 (2006.01) A61K 38/16 (2006.01) A61K 39/245 (2006.01) A61K 48/00 (2006.01) C07K 14/035 (2006.01) C12N 5/00 (2006.01) C12N 15/869 (2006.01) C12Q 1/02 (2006.01) G01N 33/50 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2132976
The present invention relates to methods of treatment of programmed cell death (apoptosis) through the use of the HSV-1 gene .gamma.1 34.5 or the product of its expression, ICP34.5. The gene and its expression have been demonstrated to be required for HSV-1 neurovirulence, and in particular, to act as an inhibitor of neuronal programmed cell death which allows for viral replication. Use of the gene therapy, or the protein itself, can be expected to result in inhibition of programmed cell death in various neurodegenerative diseases. This invention also relates to novel vectors for gene therapy, including modified herpes virus. Methods are presented for conducting assays for substances capable of mimicing, potentiating or inhibiting the expression of .gamma.1 34.5 or the activity of ICP34.5. Also, methods are disclosed for the treatment of tumorogenic diseases, including cancer, and for treatment of herpes and other viral infections using inhibitors of .gamma.1 34.5 expression or ICP34.5 activity.
Chou Joany
Roizman Bernard
Arch Development Corporation
Finlayson & Singlehurst
LandOfFree
Methods and compositions for gene, tumor, and viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for gene, tumor, and viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for gene, tumor, and viral... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1392861